Flecainide is a class IC antiarrhythmic agent that suppresses premature ventricular contractions by blocking the fast inward sodium channels during phase 0 of the cardiac action potential, thereby slowing conduction velocity and stabilizing cardiac excitability. Its primary effects include reduction of ectopic ventricular activity and prevention of arrhythmia propagation without significantly affecting repolarization duration.